|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
We previously demonstrated that genetically linking one or
more of the glycoprotein hormone-specific
subunit
genes to the common
subunit resulted in single
chain analogs that were bioactive in vitro. The ability of
such large structures to bind their cognate receptors with
high affinity supported the hypothesis that extensive
flexibility exists between the ligand and receptor to
establish a functional complex. To further characterize
the extent of this conformational flexibility, we
engineered a single chain analog that consists of
sequentially linked TSH
, FSH
and CG
subunits to the
subunit and expressed this chimera in
transfected CHO cells. Because the four subunits are
genetically linked and expressed as a single chain, this
analog presumably lacks significant native structural
features of the individual heterodimers. However, it
exhibited FSH, CG and TSH activities in vitro. Here, we
test whether this non-native structure would be stable in
vivo, and thus biologically active. Using a variety of
bioassay protocols, we demonstrate that the analog elicits
multi-hormone activities when injected in vivo. First,
treatment with the analog caused increases in ovarian and
uterine weights and resulted in elevated serum estradiol.
Second, the analog stimulated ovarian follicle growth and
pharmacologically rescued in vivo FSH deficiency similar
to recombinant hFSH or PMSG as confirmed by induction of
aromatase in the ovaries of FSH
knockout mice.
Third, in a superovulation protocol, when primed with
PMSG, the analog elicited a dose-dependent ovulatory
response comparable to that by native heterodimeric hCG.
Finally, the analog stimulated thyroxin production in
hypothyroid mice similar to the pituitary--derived human
TSH standard. Based on these data, we conclude that a
single chain tetradomain glycoprotein hormone analog,
despite its presumed altered conformation is stable and
biologically active in vivo. Our results establish the
permissiveness and conformational plasticity with which
the glycoprotein hormones are recognized in vivo by their
target cell receptors.
Key words:
Pituitary
Follicle-stimulating hormone
Luteinizing hormone
Ovulation
Thyroid-stimulating hormone
This article has been cited by other articles:
![]() |
A. Jablonka-Shariff, T. R. Kumar, J. Eklund, A. Comstock, and I. Boime Single-Chain, Triple-Domain Gonadotropin Analogs with Disulfide Bond Mutations in the {alpha}-Subunit Elicit Dual Follitropin and Lutropin Activities in Vivo Mol. Endocrinol., June 1, 2006; 20(6): 1437 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
T R. Kumar What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice? Reproduction, September 1, 2005; 130(3): 293 - 302. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |